The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide Synthesis
Open accessAbstract
Small molecule therapeutics represent the majority of the FDA-approved drugs. Yet, many attractive targets are poorly tractable by small molecules, generating a need for new therapeutic modalities. Due to their biocompatibility profile and structural versatility, peptide-based therapeutics are a possible solution. Additionally, in the past two decades, advances in peptide design, delivery, formulation, and devices have occurred, making therapeutic peptides an attractive modality. However, peptide manufacturing is often limited to solid-phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and to a lesser extent hybrid SPPS/LPPS, with SPPS emerging as a predominant platform technology for peptide synthesis. SPPS involves the use of excess solvents and reagents which negatively impact the environment, thus highlighting the need for newer technologies to reduce the environmental footprint. Herein, fourteen American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable (ACS GCIPR) member companies with peptide-based therapeutics in their portfolio have compiled Process Mass Intensity (PMI) metrics to help inform the sustainability efforts in peptide synthesis. This includes PMI assessment on 40 synthetic peptide processes at various development stages in pharma, classified according to the development phase. This is the most comprehensive assessment of synthetic peptide environmental metrics to date. The synthetic peptide manufacturing process was divided into stages (synthesis, purification, isolation) to determine their respective PMI. On average, solid-phase peptide synthesis (SPPS) (PMI ≈ 13,000) does not compare favorably with other modalities such as small molecules (PMI median 168-308) and biopharmaceuticals (PMI ≈ 8300). Thus, the high PMI for peptide synthesis warrants more environmentally friendly processes in peptide manufacturing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green Chemistry: Theory and Practice
Anastas, P. T., & Warner, J. C. (1998) · Medical Entomology and Zoology · Cited by 8,599
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T., & Cuervo, J. H. (1991) · Nature · doi:10.1038/354084a0 · Cited by 1,326
Metrics of Green Chemistry and Sustainability: Past, Present, and Future
Sheldon, R. A. (2018) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.7b03505 · Cited by 1,292
Peer Reviewed: Design Through the 12 Principles of Green Engineering
Anastas, P. T., & Zimmerman, J. B. (2003) · Environmental Science & Technology · doi:10.1021/es032373g · Cited by 1,273
Metrics to ‘green’ chemistry—which are the best?
Constable, D. J. C., Curzons, A. D., & Cunningham, V. L. (2002) · Green Chem. · doi:10.1039/b206169b · Cited by 910
Jimenez-Gonzalez, C., Ponder, C. S., Broxterman, Q. B., & Manley, J. B. (2011) · Organic Process Research & Development · doi:10.1021/op200097d · Cited by 910
Isidro-Llobet, A., Álvarez, M., & Albericio, F. (2009) · Chemical Reviews · doi:10.1021/cr800323s · Cited by 850
Self-citationLarge-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals
Dunetz, J. R., Magano, J., & Weisenburger, G. A. (2016) · Organic Process Research & Development · doi:10.1021/op500305s · Cited by 819
Research works printed but not linked: 7
- Blaha K., 2004, Chemicke Listy, 98, 875
- Sisniega E. C., 2008, Dyna, 83, 382
- Aguilar M. I., 2004, Methods in Molecular Biology, HPLC of Peptides and Proteins, Methods and Protocols
- Ludemann-Hombourger O., 2021, Chemistry Today, 39, 50
- Agency E. C., Restrictions on the Manufacture, Placing on the Market and Use of Certain Dangerous Substances, Mixtures and Articles
- Ravetti Duran R., 2022, Speciality Chemicals Magazine, 2022, 40
- Al Musaimi O., 2021, Chemistry Today, 39, 42
Cited by
Pang, T., Xue, Z., Wang, G., Li, J., Sui, W., & Si, C. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202503195 · Cited by 85
Recent advances in green chemistry approaches for pharmaceutical synthesis
Ahmad, S., Jaiswal, R., Yadav, R., & Verma, S. (2024) · Sustainable Chemistry One World · doi:10.1016/j.scowo.2024.100029 · Cited by 95
From lead to market: chemical approaches to transform peptides into therapeutics
Gare, C. L., White, A. M., & Malins, L. R. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.01.009 · Cited by 61
Solvent Sustainability in Drug Discovery: Where Are We Now, and How Can We Improve?
Richardson, P., Bryan, M. C., Diorazio, L. J., Gallou, F., Keily, S. B., Martínez, I., Plummer, S., Reed, A. B., Sheppard, R. J., Shields, J. D., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01220 · Cited by 38
Self-citationContinuous-Flow Solid-Phase Peptide Synthesis to Enable Rapid, Multigram Deliveries of Peptides
Ruhl, K. E., Maso, M. J. D., Rose, H. B., Schultz, D. M., Lévesque, F., Grosser, S. T., Silverman, S. M., Li, S., Sciammetta, N., & Mansoor, U. F. (2024) · Organic Process Research & Development · doi:10.1021/acs.oprd.4c00165 · Cited by 35
Metadata
- Authors
- Kekessie, I., Wegner, K., Martinez, I., Kopach, M. E., White, T. D., Tom, J. K., Kenworthy, M. N., Gallou, F., Lopez, J., Koenig, S. G., Payne, P. R., Eissler, S., Arumugam, B., Li, C., Mukherjee, S., Isidro-Llobet, A., Ludemann-Hombourger, O., Richardson, P., Kittelmann, J., Sejer Pedersen, D., & van den Bos, L. J.
- Affiliations
- Roche (United States) (US)
- Ipsen (Ireland) (IE)
- Green Chemistry Institute, American Chemical Society, 1155 16th St North West, Washington, District of Columbia, 20036, United States
- Eli Lilly (United States) (US)
- Amgen (United States) (US)
- AstraZeneca (United Kingdom) (GB)
- Novartis (Switzerland) (CH)
- Outsourced Manufacturing, Pharmaceutical Development & Manufacturing, Gilead Alberta ULC, 1021 Hayter Rd NW, Edmonton, T6S 1A1, Canada
- Bachem (Switzerland) (CH)
- Tianjin Economic-Technological Development Area (CN)
- Bristol-Myers Squibb (United States) (US)
- GSK, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
- PolyPeptide Laboratories France SAS, 7 Rue de Boulogne, 67100 Strasbourg, France
- Pfizer (United States) (US)
- CMC API Development, Novo Allé, 2880 Bagsværd, Denmark
- Chemical Development, Novo Allé, CMC API Development, 2880 Bagsværd, Denmark
- EnzyTag B.V, Daelderweg 9, 6361HK, Nuth, Netherlands
- Corresponding author
- Kekessie, Ivy
- ORCID
- Venue
- The Journal of Organic Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2024-03-20
- Volume
- 89
- Issue
- 7
- Pages
- 4261-4282
- ISSN
- 0022-3263 (ISSN-L)
- 1520-6904
- PMC
- PMC11002941
- OpenAlex
- W4393022591
- Cited by
- 149
- References
- 126
- Citations by year
- 2026: 74 · 2025: 60 · 2024: 15
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Organic Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- The Novartis Repository (Novartis) (submittedVersion)
- Funders
- American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Chemistry and Chemical Engineering
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Physical Sciences › Environmental Science › Environmental Engineering › Environmental Impact and Sustainability
- Keywords
- process mass intensity, solid-phase peptide synthesis, liquid-phase peptide synthesis, green chemistry, environmental footprint, peptide therapeutics, peptide purification
- MeSH terms
- Peptides, Solvents, Chemistry Techniques, Synthetic, Solid-Phase Synthesis Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.